Novel Diagnostics With Optical Coherence Tomography: Retinal Imaging
| Status: | Recruiting |
|---|---|
| Conditions: | Ocular, Diabetes |
| Therapuetic Areas: | Endocrinology, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 2/7/2018 |
| Start Date: | October 2005 |
| End Date: | January 2020 |
| Contact: | Catherine Randall |
| Email: | catherine.randall@nyumc.org |
| Phone: | 212 263 7563 |
The purpose of this research is to evaluate optical coherence tomography (OCT) and FDA
approved device used to image diseases of the eye. The ultra-high resolution OCT is a
non-significant risk device used in this study. Optical Coherence Tomography may be useful
for early diagnosis and monitoring of different types of eye diseases.
approved device used to image diseases of the eye. The ultra-high resolution OCT is a
non-significant risk device used in this study. Optical Coherence Tomography may be useful
for early diagnosis and monitoring of different types of eye diseases.
The purpose of this research is to evaluate optical coherence tomography (OCT) and FDA
approved device used to image diseases of the eye. The ultra-high resolution OCT is a
non-significant risk device used in this study. OCT may be useful for early diagnosis and
monitoring of different types of eye diseases.
approved device used to image diseases of the eye. The ultra-high resolution OCT is a
non-significant risk device used in this study. OCT may be useful for early diagnosis and
monitoring of different types of eye diseases.
Inclusion Criteria:
- Subjects with healthy eyes, macular degeneration, glaucoma and other various eye
diseases. Also must be able to fixate on target.
Exclusion Criteria:
- If the fundus is not visible if the media is opaque and if they are unwilling to
participate.
We found this trial at
1
site
Click here to add this to my saved trials
